Seeing Is Believing
Currently out of the existing stock ratings of Shannon O'callaghan, 14 are a HOLD (20.9%), 52 are a BUY (77.61%), 1 are a SELL (1.49%).
Analyst Shannon O'callaghan, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 81.67% that have a potential upside of 36.15% achieved within 855 days.
Shannon O'callaghan’s has documented 147 price targets and ratings displayed on 15 stocks. The coverage is on Industrials, Healthcare, Technology sectors.
Most recent stock forecast was given on GH, Guardant Health at 08-Nov-2023.
Analyst best performing recommendations are on SPXC (SPX CORP).
The best stock recommendation documented was for SPXC (SPX CORP) at 8/24/2016. The price target of $23 was fulfilled within 86 days with a profit of $4.16 (22.08%) receiving and performance score of 2.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$210
$38.3 (22.31%)
$205
12 days ago
(23-Oct-2024)
3/5 (60%)
$28.31 (15.58%)
91
Buy
$200
$28.3 (16.48%)
$181
3 months 5 days ago
(30-Jul-2024)
34/38 (89.47%)
$32.52 (19.42%)
882
Buy
$190
$18.3 (10.66%)
$185
4 months 7 days ago
(28-Jun-2024)
2/2 (100%)
$31.03 (19.52%)
124
Buy
$175
$3.3 (1.92%)
$148
5 months 22 days ago
(13-May-2024)
5/5 (100%)
$15.5 (9.72%)
120
Buy
$180
$8.3 (4.83%)
$150
6 months 11 days ago
(24-Apr-2024)
7/9 (77.78%)
$20.81 (13.07%)
460
What Year was the first public recommendation made by Shannon O'callaghan?